Since DDR can reduce the effectiveness of chemotherapy agents by activating checkpoints and triggering DNA repair pathways that result in increased tumor cell drug resistance and survival, it is not surprising that ATR is a therapeutic target in cancer cells. This evidence concerns the gene ATR and cancer.